Arca Biopharma | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Amgen USD 1.69B 191M 2025-03
Biogen USD 572.5M 104.8M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Cipla INR 12.33B 354.8M 2025-03
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.37M 361K 2024-12
CSL USD 1.18B 201M 2024-12
Cytokinetics USD 57.37M 4.97M 2025-03
Daiichi Sankyo JPY 208.21B 22.58B 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Grifols EUR 269.48M 49.95M 2024-12
Laboratory Of America USD 546M 49.2M 2025-03
Myriad Genetics USD 135.7M 300K 2025-03
Otsuka Holdings JPY 232.5B 30.8B 2025-03
Pfizer USD 3.01B 1.27B 2025-03
United Therapeutics USD 170.1M 7.6M 2025-03



Arca Biopharma Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.